PRECIOUS the group
PRECIOUS the group
PRECIOUS the group

Partner 3 - Oslo universitetssykehus HF

Dr. Anne Hege Aamodt

Dr. Anne Hege Aamodt


Principal Investigator

Leader WP5





Oslo universitetssykehus HF (OUS)


Kirkeveien 166


0407 Oslo





PRECIOUS Team Oslo universitetssykehus

Hans Olav Melberg

Associate Prof. Hans Olav Melberg

Economic Evaluation


Phone: +47 93658818


Institute presentation

Oslo universitetssykehus HF (OUS) has a nationwide responsibility for a number of national and multi-regional assignments and has several national centers of competence. OUS is responsible for approximately 50 percent of all medical and healthcare research conducted at Norwegian hospitals and is a significant role player within the education of a large variety of health care personnel. The hospital is Scandinavia’s largest and each year carries out more than 1.2 million patient treatments. The aim of the hospital is to create a well functioning and efficient local hospital, to strengthen highly specialized medicine, conduct research and provide education and innovation on international levels.


The Project Leaders have long experience with health-economic evaluations. Prof Berge was responsible for the health-economic evaluation of thrombolytic treatment for stroke in the UK, commissioned by the NHS R&D Health Technology Assessment Programme, and is currently involved in the cost-/utility-analyses of the Scandinavian Candesartan Acute Stroke Trial (SCAST, Lancet 2011) and the Third Interntional Stroke Trial (IST-3). Ass Prof Melberg is Leader of the OUS research group in economic evaluation, and has been involved in a number of healh-economic evaluations commisioned by the Norwegian Government, Ministry of Finance, Ministry of Health, and the Norwegian Directorate of Health. He is currently partner in a number of international collaborations, including a project led by Prof Zeke Emmanuel (University of Pennsylvania, USA), and the Addictions and Lifestyle in Contemporary Europe – Reframing Addictions Project (ALICE-RAP), financed by the EU 7th Framework Programme. Researcher Kleven is a member of the OUS research group in economic evaluation, which provides support to research groups/clinicians/PhD candidates at the OUS and other hospitals within the South-Eastern Norway Regional Health Authority. She is also a part of the economic evaluation team in IST-3.


Main tasks attributed in the project:


OUS will be responsible for the undefinedWP 5 (health-economical analyses) in the project.


Newsletter Subscription

Social Media


Contact us

Contact us